Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivoYusuke Tarumoto, Christopher R. Vakoc|Blood|2019Cited by 81
The Salt-Inducible Kinase inhibitor YKL-05-099 suppresses MEF2C function and acute myeloid leukemia progression <i>in vivo</i>Yusuke Tarumoto, Christopher R. Vakoc|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1